Cargando…

Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda

BACKGROUND: Among HIV-infected women, perinatal depression compromises clinical, maternal, and child health outcomes. Antiretroviral therapy (ART) is associated with lower depression symptom severity but the uniformity of effect through pregnancy and postpartum periods is unknown. METHODS: We analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaida, Angela, Matthews, Lynn T., Ashaba, Scholastic, Tsai, Alexander C., Kanters, Steve, Robak, Magdalena, Psaros, Christina, Kabakyenga, Jerome, Boum, Yap, Haberer, Jessica E., Martin, Jeffrey N., Hunt, Peter W., Bangsberg, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251908/
https://www.ncbi.nlm.nih.gov/pubmed/25436816
http://dx.doi.org/10.1097/QAI.0000000000000370
_version_ 1782347113302065152
author Kaida, Angela
Matthews, Lynn T.
Ashaba, Scholastic
Tsai, Alexander C.
Kanters, Steve
Robak, Magdalena
Psaros, Christina
Kabakyenga, Jerome
Boum, Yap
Haberer, Jessica E.
Martin, Jeffrey N.
Hunt, Peter W.
Bangsberg, David R.
author_facet Kaida, Angela
Matthews, Lynn T.
Ashaba, Scholastic
Tsai, Alexander C.
Kanters, Steve
Robak, Magdalena
Psaros, Christina
Kabakyenga, Jerome
Boum, Yap
Haberer, Jessica E.
Martin, Jeffrey N.
Hunt, Peter W.
Bangsberg, David R.
author_sort Kaida, Angela
collection PubMed
description BACKGROUND: Among HIV-infected women, perinatal depression compromises clinical, maternal, and child health outcomes. Antiretroviral therapy (ART) is associated with lower depression symptom severity but the uniformity of effect through pregnancy and postpartum periods is unknown. METHODS: We analyzed prospective data from 447 HIV-infected women (18–49 years) initiating ART in rural Uganda (2005–2012). Participants completed blood work and comprehensive questionnaires quarterly. Pregnancy status was assessed by self-report. Analysis time periods were defined as currently pregnant, postpartum (0–12 months post-pregnancy outcome), or non–pregnancy-related. Depression symptom severity was measured using a modified Hopkins Symptom Checklist 15, with scores ranging from 1 to 4. Probable depression was defined as >1.75. Linear regression with generalized estimating equations was used to compare mean depression scores over the 3 periods. RESULTS: At enrollment, median age was 32 years (interquartile range: 27–37), median CD4 count was 160 cells per cubic millimeter (interquartile range: 95–245), and mean depression score was 1.75 (s = 0.58) (39% with probable depression). Over 4.1 median years of follow-up, 104 women experienced 151 pregnancies. Mean depression scores did not differ across the time periods (P = 0.75). Multivariable models yielded similar findings. Increasing time on ART, viral suppression, better physical health, and “never married” were independently associated with lower mean depression scores. Findings were consistent when assessing probable depression. CONCLUSIONS: Although the lack of association between depression and perinatal periods is reassuring, high depression prevalence at treatment initiation and continued incidence across pregnancy and non–pregnancy-related periods of follow-up highlight the critical need for mental health services for HIV-infected women to optimize both maternal and perinatal health.
format Online
Article
Text
id pubmed-4251908
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher JAIDS Journal of Acquired Immune Deficiency Syndromes
record_format MEDLINE/PubMed
spelling pubmed-42519082014-12-05 Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda Kaida, Angela Matthews, Lynn T. Ashaba, Scholastic Tsai, Alexander C. Kanters, Steve Robak, Magdalena Psaros, Christina Kabakyenga, Jerome Boum, Yap Haberer, Jessica E. Martin, Jeffrey N. Hunt, Peter W. Bangsberg, David R. J Acquir Immune Defic Syndr Supplement Article BACKGROUND: Among HIV-infected women, perinatal depression compromises clinical, maternal, and child health outcomes. Antiretroviral therapy (ART) is associated with lower depression symptom severity but the uniformity of effect through pregnancy and postpartum periods is unknown. METHODS: We analyzed prospective data from 447 HIV-infected women (18–49 years) initiating ART in rural Uganda (2005–2012). Participants completed blood work and comprehensive questionnaires quarterly. Pregnancy status was assessed by self-report. Analysis time periods were defined as currently pregnant, postpartum (0–12 months post-pregnancy outcome), or non–pregnancy-related. Depression symptom severity was measured using a modified Hopkins Symptom Checklist 15, with scores ranging from 1 to 4. Probable depression was defined as >1.75. Linear regression with generalized estimating equations was used to compare mean depression scores over the 3 periods. RESULTS: At enrollment, median age was 32 years (interquartile range: 27–37), median CD4 count was 160 cells per cubic millimeter (interquartile range: 95–245), and mean depression score was 1.75 (s = 0.58) (39% with probable depression). Over 4.1 median years of follow-up, 104 women experienced 151 pregnancies. Mean depression scores did not differ across the time periods (P = 0.75). Multivariable models yielded similar findings. Increasing time on ART, viral suppression, better physical health, and “never married” were independently associated with lower mean depression scores. Findings were consistent when assessing probable depression. CONCLUSIONS: Although the lack of association between depression and perinatal periods is reassuring, high depression prevalence at treatment initiation and continued incidence across pregnancy and non–pregnancy-related periods of follow-up highlight the critical need for mental health services for HIV-infected women to optimize both maternal and perinatal health. JAIDS Journal of Acquired Immune Deficiency Syndromes 2014-12-01 2014-11-07 /pmc/articles/PMC4251908/ /pubmed/25436816 http://dx.doi.org/10.1097/QAI.0000000000000370 Text en Copyright © 2014 by Lippincott Williams & Wilkins This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivitives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Supplement Article
Kaida, Angela
Matthews, Lynn T.
Ashaba, Scholastic
Tsai, Alexander C.
Kanters, Steve
Robak, Magdalena
Psaros, Christina
Kabakyenga, Jerome
Boum, Yap
Haberer, Jessica E.
Martin, Jeffrey N.
Hunt, Peter W.
Bangsberg, David R.
Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda
title Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda
title_full Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda
title_fullStr Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda
title_full_unstemmed Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda
title_short Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda
title_sort depression during pregnancy and the postpartum among hiv-infected women on antiretroviral therapy in uganda
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251908/
https://www.ncbi.nlm.nih.gov/pubmed/25436816
http://dx.doi.org/10.1097/QAI.0000000000000370
work_keys_str_mv AT kaidaangela depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT matthewslynnt depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT ashabascholastic depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT tsaialexanderc depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT kanterssteve depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT robakmagdalena depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT psaroschristina depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT kabakyengajerome depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT boumyap depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT habererjessicae depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT martinjeffreyn depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT huntpeterw depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda
AT bangsbergdavidr depressionduringpregnancyandthepostpartumamonghivinfectedwomenonantiretroviraltherapyinuganda